| ORIGINAL ARTICLE |
|
| Year : 2023 | Volume
: 14
| Issue : 1 | Page : 35-40 |
|
|
High D-Dimer level at first incident cancer-associated venous thromboembolism is a predictor for recurrence: A retrospective cohort study
Fahad A S. Al-Eidan1, Shaden A Alotaibi2, Hind M Almajid2, Taghreed A Alnahedh2, Abdel Galil Abdel Gadir2
1 Academic and Students Affairs Department, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Health Affairs, Ministry of National Guard; King Abdulaziz Medical City, Health Affairs, Ministry of National Guard; King Abdullah International Medical Research Centre, Health Affairs Ministry of National Guard, Riyadh, Saudi Arabia
2 Academic and Students Affairs Department, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Health Affairs, Ministry of National Guard; King Abdullah International Medical Research Centre, Health Affairs Ministry of National Guard, Riyadh, Saudi Arabia
Correspondence Address:
Prof. Fahad A S. Al-Eidan
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Health Affairs, Ministry of National Guard, Riyadh
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/joah.joah_107_22
|
|
|
BACKGROUND: Cancer is considered a major risk factor of venous thromboembolism (VTE). Whether the D-dimer level at first incident cancer-associated VTE can predict recurrence is not fully elucidated.
AIM: The aim of this study was to assess the association between D-dimer level measured at first incident cancer-associated VTE and risk of recurrence.
METHODS: In this study, the electronic records of all patients with first incident cancer-associated VTE were retrospectively retrieved and followed up for a period of 36 months. The measured levels of D-dimer and clinical predictors for each patient prior intervention were collected. Univariate and multivariant Cox regressions were fitted to estimate the hazard ratio (HR) and 95% confidence interval (CI).
RESULTS: A total of 73 (34.3%) of 213 cancer-associated VTE patients had recurrent VTE. The crude recurrence rate was 11.4/100 person-years (95% CI, 9.2–14.2). The mean value of D-dimer was significantly higher seen in recurrent VTE patients than those without recurrence (14.8 ± 7.5 mg/L vs. 4.8 ± 5.7 mg/L, P < 0.001). The highest positive likelihood ratio using area under the receiver operating characteristic (ROC) curve occurred when a D-dimer threshold of 8.67 mg/L was chosen. At this threshold, the D-dimer was 92% sensitive and 80% specific in predicting recurrent VTE. The area under the ROC curve was 0.924 (95% CI 0.887–0.960, P < 0.001). Patients with a D-dimer ≥8.67 mg/L at first VTE in our study were 3.1-fold more likely to have a recurrence than those with lower D-dimer results.
CONCLUSION: A D-dimer ≥8.67 mg/L measured at the first incident cancer-associated VTE was associated with a 3.1-fold increased hazard of recurrence events. Our finding suggests that a low D-dimer level at the time of first cancer-associated VTE is suitable in the clinical practice to avoid extended-duration anticoagulation.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
